292 related articles for article (PubMed ID: 28319053)
21. Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions.
Pan YX; Xu J; Xu M; Rossi GC; Matulonis JE; Pasternak GW
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4917-22. PubMed ID: 19273844
[TBL] [Abstract][Full Text] [Related]
22. Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.
Sim-Selley LJ; Scoggins KL; Cassidy MP; Smith LA; Dewey WL; Smith FL; Selley DE
Br J Pharmacol; 2007 Aug; 151(8):1324-33. PubMed ID: 17572699
[TBL] [Abstract][Full Text] [Related]
23. Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P.
Xu J; Xu M; Bolan E; Gilbert AK; Pasternak GW; Pan YX
Synapse; 2014 Apr; 68(4):144-52. PubMed ID: 24375714
[TBL] [Abstract][Full Text] [Related]
24. Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene,
Liu S; Kang WJ; Abrimian A; Xu J; Cartegni L; Majumdar S; Hesketh P; Bekker A; Pan YX
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680158
[TBL] [Abstract][Full Text] [Related]
25. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
Madia PA; Navani DM; Yoburn BC
Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
[TBL] [Abstract][Full Text] [Related]
26. Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.
Chakrabarti S; Liu NJ; Gintzler AR
Cell Mol Neurobiol; 2021 Jul; 41(5):855-862. PubMed ID: 32804312
[TBL] [Abstract][Full Text] [Related]
27. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
[TBL] [Abstract][Full Text] [Related]
28. Involvement of kappa opioid receptors in the formalin-induced inhibition of analgesic tolerance to morphine via suppression of conventional protein kinase C activation.
Fujita-Hamabe W; Nagae R; Nawa A; Harada S; Nakamoto K; Tokuyama S
J Pharm Pharmacol; 2010 Aug; 62(8):995-1002. PubMed ID: 20663033
[TBL] [Abstract][Full Text] [Related]
29. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
30. A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal.
Grim TW; Schmid CL; Stahl EL; Pantouli F; Ho JH; Acevedo-Canabal A; Kennedy NM; Cameron MD; Bannister TD; Bohn LM
Neuropsychopharmacology; 2020 Jan; 45(2):416-425. PubMed ID: 31443104
[TBL] [Abstract][Full Text] [Related]
31. Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107.
Lu Z; Xu J; Xu M; Pasternak GW; Pan YX
Mol Pharmacol; 2014 Feb; 85(2):368-80. PubMed ID: 24302561
[TBL] [Abstract][Full Text] [Related]
32. Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the mu-opioid receptor.
Heinzen EL; Booth RG; Pollack GM
Biochem Pharmacol; 2005 Feb; 69(4):679-88. PubMed ID: 15670586
[TBL] [Abstract][Full Text] [Related]
33. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
34. Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.
Xu J; Xu M; Brown T; Rossi GC; Hurd YL; Inturrisi CE; Pasternak GW; Pan YX
J Biol Chem; 2013 Jul; 288(29):21211-21227. PubMed ID: 23760268
[TBL] [Abstract][Full Text] [Related]
35. The biochemical analysis of methadone modulation on morphine-induced tolerance and dependence in the rat brain.
He L; Whistler JL
Pharmacology; 2007; 79(4):193-202. PubMed ID: 17356311
[TBL] [Abstract][Full Text] [Related]
36. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor.
Rossi GC; Pan YX; Brown GP; Pasternak GW
FEBS Lett; 1995 Aug; 369(2-3):192-6. PubMed ID: 7649256
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of the murine mu opioid receptor: increased complexity of Oprm gene splicing.
Kvam TM; Baar C; Rakvåg TT; Kaasa S; Krokan HE; Skorpen F
J Mol Med (Berl); 2004 Apr; 82(4):250-5. PubMed ID: 14991152
[TBL] [Abstract][Full Text] [Related]
38. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of a novel mu-opioid receptor (MOR) subtype MOR-1B in CXBK mice: implications of MOR-1B in the expression of MOR-mediated responses.
Narita M; Imai S; Ozaki S; Suzuki M; Narita M; Suzuki T
Eur J Neurosci; 2003 Dec; 18(12):3193-8. PubMed ID: 14686893
[TBL] [Abstract][Full Text] [Related]
40. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
